SECTION 1: PROBLEM
MANUFACTURING
WE ARE GOING TO FIX IT
Cell therapy depends on the patient to work.
Some immune cells eat. When they clear a dying stem cell, they change their behavior — from attack to repair. Today’s stem cell therapies leave that moment to the patient’s body, and when the body can’t trigger it, the therapy fails. Humap leverages this capacity to eat: our stem cells are prepared in advance, ready to reprogram immune cells toward balance.
+ Learn More about our engineering approachHow We Engineer Intelligent Stem Cells
Not asking for permission.
A second-time biotech founder and a team spanning genomics, cell biology, and molecular genetics — built to take an engineered cell therapy from bench to IND.
Sebastian Peñaherrera
Fundador
Paul Cardenas PhD
Pedro Aponte PhD
Juan Carlos Fernandez PhD



